Unjha Formul.

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE576D01015
  • NSEID:
  • BSEID: 531762
INR
23.62
-1.57 (-6.23%)
BSENSE

Dec 05

BSE+NSE Vol: 16

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -25.05% vs 40.61% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -10.47% vs 32.86% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -85.11% vs -6.04% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 46.64% vs -1.63% in Mar 2024

Compare Profit and Loss Results of Unjha Formul.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
13.00
21.00
-8.00
-38.10%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13.00
21.00
-8.00
-38.10%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
11.00
11.00
0.00
0.00%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
0.00
2.00
-2.00
-100.00%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2.00
-2.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
13.00
19.00
-6.00
-31.58%
Operating Profit (PBDIT) excl Other Income
0.00
1.00
-1.00
-100.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
0.00
2.00
-2.00
-100.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
2.00
-2.00
-100.00%
Depreciation
0.00
1.00
-1.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
0.00
0.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-1.00
3.00
-4.00
-133.33%
Profit Available for appropriations
-1.00
4.00
-5.00
-125.00%
Appropriations
-1.00
4.00
-5.00
-125.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.91
1.14
-0.23
-20.18%
Profit And Loss - Net Sales
Net Sales 13.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -25.05% vs 40.61% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -10.47% vs 32.86% in Mar 2024

Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -85.11% vs -6.04% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 46.64% vs -1.63% in Mar 2024